Patents by Inventor Harish Kumar Madan

Harish Kumar Madan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20170326092
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: August 2, 2017
    Publication date: November 16, 2017
    Inventors: Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Harish Kumar MADAN, Ravi KOCHHAR, Simon Santosh JENA, Rajesh RAO, Anuj Kumar FANDA, Romi Barat SINGH
  • LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20170326091
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: August 1, 2017
    Publication date: November 16, 2017
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • Low dose oral pharmaceutical composition of isotretinoin
    Patent number: 9750711
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: September 5, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Harish Kumar Madan, Rathinasabapathy Venkateshwaran, Sumit Madan, Ravi Kochhar
  • LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20170165218
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect, in particular no food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 15, 2017
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160128962
    Abstract: The present invention provides a low dose oral pharmaceutical composition of isotretinoin having reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: May 12, 2016
    Inventors: Harish Kumar MADAN, Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Ravi KOCHHAR
  • ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
    Publication number: 20160081965
    Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 24, 2016
    Inventors: Rathinasabapathy VENKATESHWARAN, Sumit MADAN, Harish Kumar MADAN, Ravi KOCHHAR, Simon Santosh JENA, Rajesh RAO, Anuj Kumar FANDA, Romi Barat SINGH
  • Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
    Patent number: 8664265
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: March 4, 2014
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Arno Appavoo Enose, Harish Kumar Madan, Sumit Madan, Anupam Trehan, Puneet Tyagi, Vinod Kumar Arora
  • STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS
    Publication number: 20120183607
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Arno Appavoo ENOSE, Harish Kumar MADAN, Sumit MADAN, Anupam TREHAN, Puneet TYAGI, Vinod Kumar ARORA
  • STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS
    Publication number: 20090042821
    Abstract: The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
    Type: Application
    Filed: May 18, 2006
    Publication date: February 12, 2009
    Inventors: Arno Appavoo Enose, Harish Kumar Madan, Sumit Madan, Anupam Trehan, Puneet Tyagi, Vinod Kumar Arora